(Q36430753)

14 August 2017

1 reference

title

Risk prediction models for familial breast cancer. (English)

1 reference

14 August 2017

1 reference

2

Douglas F Easton

1 reference

14 August 2017

1

Antonis C Antoniou

1 reference

PubMed ID

16563094

14 August 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

14 August 2017

1 reference

14 August 2017

2

1 reference

14 August 2017

257-274

1 reference

14 August 2017

2

1 reference

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

14 August 2017

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Radiation and breast cancer: a review of current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

The genetic epidemiology of breast cancer genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Cancer risks and mortality in heterozygous ATM mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Predictive genetic tests: problems and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Validation studies for models projecting the risk of invasive and total breast cancer incidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Complex segregation analysis with pointers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

A breast cancer prediction model incorporating familial and personal risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Familial breast and ovarian cancer: a Swedish population-based register study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Modifiers of risk of hereditary breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

The BOADICEA model of genetic susceptibility to breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Assessing BRCA carrier probabilities in extended families.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Validation of a breast cancer risk assessment model in women with a positive family history.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Validation of the Gail et al. model for predicting individual breast cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Relationship Between Mammographic and Histological Risk Factors for Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Effects of mammographic density and benign breast disease on breast cancer risk (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Quantitative Assessment of Mammographic Breast Density: Relationship with Breast Cancer Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Heritability of mammographic density, a risk factor for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Cancer risks in BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

BRCA mutations and risk of prostate cancer in Ashkenazi Jews.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Cancer Incidence in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Validation of family history data in cancer family registries

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

The importance of a family history of breast cancer in predicting the presence of a BRCA mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Modeling the probability that Ashkenazi Jewish women carry a founder mutation in BRCA1 or BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.257

21 January 2018

Identifiers

DOI

10.2217/14796694.2.2.257

1 reference

14 August 2017

1 reference

PubMed ID

16563094